| Pharmaceutical active ingredients: |
| HydrochlorothiazideIrbesartan |
| Available forms, composition and doses of Adana Plus: |
| N / A |
| Adana Plus medical category: |
| Human:Angiotensin II receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09DA04 - Irbesartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sandoz |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Xenia | Hydrochlorothiazide | USV, India |
| Zide | Hydrochlorothiazide | Solvay |
| Dynyel | Hydrochlorothiazide Hydrochloride; Ramipril | Raam de Sahuayo Laboratorios |
| Norplus | Hydrochlorothiazide; Imidapril Hydrochloride | L.R. Imperial Pharmaceuticals; United Laboratories |
| Vascoride | Hydrochlorothiazide; Imidapril Hydrochloride | Therapharma; United Laboratories |
| Aprovel HCT | Hydrochlorothiazide; Irbesartan | Sanofi-Aventis |
| Aprozide | Hydrochlorothiazide; Irbesartan | Sanofi-Aventis; The Harvard Drug Group |
| Avalide | Hydrochlorothiazide; Irbesartan | Sanofi-Aventis; Bristol-Myers Squibb |
| Avapro HCT | Hydrochlorothiazide; Irbesartan | Bristol-Myers Squibb |
| CO Irbesartan / HCT | Hydrochlorothiazide; Irbesartan | Cobalt Pharmaceuticals |